MedPath

Christian Hinrichs

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Phase 2
Recruiting
Conditions
Anal Cancer
Vulva Cancer
Metastatic Cancer
HPV-Related Squamous Cell Carcinoma
HPV-Related Adenocarcinoma
HPV-Associated Vaginal Adenocarcinoma
HPV-Related Anal Squamous Cell Carcinoma
HPV-Related Penile Squamous Cell Carcinoma
HPV-Related Malignancy
HPV-Related Cervical Carcinoma
Interventions
First Posted Date
2023-01-17
Last Posted Date
2025-03-30
Lead Sponsor
Christian Hinrichs
Target Recruit Count
20
Registration Number
NCT05686226
Locations
🇺🇸

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

🇺🇸

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Phase 1
Recruiting
Conditions
Oropharynx Cancer
HPV-Associated Cervical Carcinoma
HPV-Related Carcinoma
HPV-Related Malignancy
HPV Positive Oropharyngeal Squamous Cell Carcinoma
HPV-Related Adenocarcinoma
HPV-Related Adenosquamous Carcinoma
HPV-Related Squamous Cell Carcinoma
HPV-Related Penile Squamous Cell Carcinoma
HPV-Related Endocervical Adenocarcinoma
Interventions
First Posted Date
2022-12-07
Last Posted Date
2025-03-30
Lead Sponsor
Christian Hinrichs
Target Recruit Count
15
Registration Number
NCT05639972
Locations
🇺🇸

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

🇺🇸

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

Phase 1
Recruiting
Conditions
Gastric Cancer
Cervical Cancer
Breast Cancer
Lung Cancer
Interventions
First Posted Date
2022-08-02
Last Posted Date
2025-03-30
Lead Sponsor
Christian Hinrichs
Target Recruit Count
30
Registration Number
NCT05483491
Locations
🇺🇸

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

🇺🇸

RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.